CA2156416A1 - Peptides pour l'induction de reactions cytotoxiques des lymphocytes t au virus de l'hepatite b - Google Patents

Peptides pour l'induction de reactions cytotoxiques des lymphocytes t au virus de l'hepatite b

Info

Publication number
CA2156416A1
CA2156416A1 CA002156416A CA2156416A CA2156416A1 CA 2156416 A1 CA2156416 A1 CA 2156416A1 CA 002156416 A CA002156416 A CA 002156416A CA 2156416 A CA2156416 A CA 2156416A CA 2156416 A1 CA2156416 A1 CA 2156416A1
Authority
CA
Canada
Prior art keywords
peptides
virus
hepatitis
lymphocyte responses
inducing cytotoxic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002156416A
Other languages
English (en)
Other versions
CA2156416C (fr
Inventor
Francis V. Chisari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Francis V. Chisari
The Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Francis V. Chisari, The Scripps Research Institute filed Critical Francis V. Chisari
Priority to CA002594184A priority Critical patent/CA2594184A1/fr
Priority claimed from PCT/US1994/002195 external-priority patent/WO1994019011A1/fr
Publication of CA2156416A1 publication Critical patent/CA2156416A1/fr
Application granted granted Critical
Publication of CA2156416C publication Critical patent/CA2156416C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002156416A 1993-02-26 1994-02-25 Peptides pour l'induction de reactions cytotoxiques des lymphocytes t au virus de l'hepatite b Expired - Fee Related CA2156416C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002594184A CA2594184A1 (fr) 1993-02-26 1994-02-25 Peptides pour l'induction de reactions cytotoxiques des lymphocytes t au virus de l'hepatite b

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2412093A 1993-02-26 1993-02-26
US08/024,120 1993-02-26
PCT/US1994/002195 WO1994019011A1 (fr) 1993-02-26 1994-02-25 Peptides utilises pour induire des reponses aux lymphocytes t cytotoxiques contre le virus de l'hepatite b

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA002594184A Division CA2594184A1 (fr) 1993-02-26 1994-02-25 Peptides pour l'induction de reactions cytotoxiques des lymphocytes t au virus de l'hepatite b

Publications (2)

Publication Number Publication Date
CA2156416A1 true CA2156416A1 (fr) 1994-09-01
CA2156416C CA2156416C (fr) 2007-10-09

Family

ID=38596200

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002156416A Expired - Fee Related CA2156416C (fr) 1993-02-26 1994-02-25 Peptides pour l'induction de reactions cytotoxiques des lymphocytes t au virus de l'hepatite b

Country Status (1)

Country Link
CA (1) CA2156416C (fr)

Also Published As

Publication number Publication date
CA2156416C (fr) 2007-10-09

Similar Documents

Publication Publication Date Title
CA2168583A1 (fr) Peptides induisant des reactions cytotoxiques des lymphocytes t contre le virus de l'hepatite b
EP0687182A4 (fr) Peptides utilises pour induire des reponses aux lymphocytes t cytotoxiques contre le virus de l'hepatite b
ZA964694B (en) Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection.
CA2115927A1 (fr) Peptides pour l'induction de reponses des lymphocytes t cytotoxiques contre le virus de l'hepatite b
EP1018344A3 (fr) Epitopes du virus de l'hépatite B induisant une réponse CTL rétrécie par HLA
DE69840383D1 (de) Ctl epitope des epstein-barr virus
PL297849A1 (en) Vaccine against and method of treating the patients infectedwith hiv virus
EP0631506A4 (fr) Vaccins comprenant les proteines d'enveloppe du virus de l'immunodeficience humaine de type 1 selectivement deglycosylees.
CA2192512A1 (fr) Anticorps monoclonal nmo3; methodes d'utilisation
FR2669346B1 (fr) Vaccin a poxvirus recombinant contre le virus de la rougeole.
FR2689398B1 (fr) Compositions destinées au traitement de l'infection et des maladies provoquées par le virus de l'hépatite B (HBV).
AU1308188A (en) Methods of treating acquired immune deficiency syndrome (AIDS) caused by human immunodeficiency virus (HIV)
RU93053037A (ru) Вакцина против заболевания сумки птиц и способы лечения
CA2156416A1 (fr) Peptides pour l'induction de reactions cytotoxiques des lymphocytes t au virus de l'hepatite b
CA2133108A1 (fr) Vaccin a base de toxoide contre pasteurella haemolytica type a-1
ATE111485T1 (de) Peptidbehandlung von hartnäckigen infektionskrankheiten.
FI930519A (fi) Peptider foer blokering av infektioner orsakade av hiv-virus samt foerfarande foer deras anvaendnig
AU627540B2 (en) Drug for the treatment or prevention by passive immunization, of the hiv-infection and process for preparation thereof
RU94032103A (ru) Пептиды, фармацевтическая композиция, вакцина, конъюгат, способы лечения и идентификации
IL143675A0 (en) Hepatitis c virus infection diagnostics and vaccines
CS8904172A1 (en) Nonspecific bacterial vaccine for prevention and therapy of bacterial,fungal and viral infections

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20130225